Flexion Therapeutics reported $-30312000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Aerie Pharmaceuticals AERI:US $ -33.31M 2.2M
Anika Therapeutics ANIK:US $ 1.25M 7.88M
Arena Pharmaceuticals ARNA:US $ -126.31M 19.78M
Cara Therapeutics CARA:US $ -1013000 29.73M
Chemocentryx CCXI:US $ -22.31M 16.9M
Dicerna Pharmaceuticals DRNA:US $ -16.26M 24.01M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Endo International Ordinary Shares ENDP:US $ 220.65M 39.03M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Immunogen IMGN:US $ -37.34M 6.6M
Insmed INSM:US $ -115292000 1.41M
Johnson & Johnson JNJ:US $ 8058M 282M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Macrogenics MGNX:US $ -52.89M 12.95M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Teva Pharmaceutical Industries TEVA:US $ 807M 13M
Xencor XNCR:US $ -40.19M 92.44M
Zogenix ZGNX:US $ -58M 0.89M